BiOkuris Newsroom

Explore our recent announcements, media coverage, and expert analyses to stay informed about our ongoing efforts to innovate and provide effective solutions for those affected by gastrointestinal conditions. Here, we share our progress, from pre-clinical developments and clinical trials to our achievements in bringing our commercial products to the people who need them most.

Stay connected with BiOkuris on Linkedin

26/03/2024 : First patient enrolled in our relieve study!

03/04/2024 : BiOkuris is nominated as a finalist for the NutraIngredients Awards! 

06/05/2024 : BiOkuris’ lastest paper on chitin-glucan

07/05/2024 : ISO 9001

15/05/2024 : BiOkuris’ chitin glucan has won the jurys award of the most sustainable ingredient!

28/05/2024: Our first clinical paper on BK001

07-10/09/2024 : BiOkuris at the 46th ESPEN Congress in Milan.

12-13/09/2024 : BiOkuris is at Pharmasynergy in Paris on 12 and 13 September.

23/09/20024 : Our fungal chitin-glucan is now Monash University Low FODMAP Certified™!

25/09/2024 : Good news for IBS patients… The investigator meeting of Vitabiotic study 

05/10/2024 : Truly excited to announce the publication of our preclinical study!

08-10/10/2024: BiOkuris is excited to attend CPHI in Milan.

11-15/10/2024: BiOkuris is excited to share that Prof. Edouard Louis will present our poster at UEG Week